Format

Send to:

Choose Destination
See comment in PubMed Commons below
Inflamm Res. 2009 Jan;58(1):30-7. doi: 10.1007/s00011-008-8156-9.

Activation by C5a of endothelial cell caspase 8 and cFLIP.

Author information

  • 1Department of Biology and Physics, Kennesaw State University, Kennesaw, GA 30144, USA.

Abstract

OBJECTIVES AND DESIGN:

In this study, we examine the relationship between C5a and activation of cysteine aspartic acid protease 8 (caspase 8) in human umbilical vein endothelial cells (HUVEC).

MATERIALS OR SUBJECTS:

Primary cultures of HUVEC were used.

TREATMENTS:

Recombinant human C5a (50 ng/ml) was used in the presence or absence of 10 microg/ml cycloheximide (CHX).

METHODS:

HUVEC were treated with C5a alone and in the presence of CHX, then monitored for cell viability, poly- ADP-ribose 1 (PARP-1) and caspase 8 activities. Gene and protein expressions were assessed for caspase 8 and the caspase 8 homologue, FLICE -inhibitory protein (cFLIP).

RESULTS:

We found a 43.1 +/- 6.9 percent reduction in viability of HUVEC stimulated for 18 h with 50 ng/ml C5a in the presence of 10 microg/ml CHX (p < 0.05). In contrast, the cell viability of cells stimulated for 18 h with 50 ng/ml C5a or 10 microg/ml CHX alone was not significantly different compared to the non-stimulated control. Treatment of HUVEC with C5a induced an increase in caspase 8 activity but did not significantly affect cFLIP levels.

CONCLUSIONS:

These data suggest caspase 8 activation induced by C5a leads to cell death if protein synthesis of antiapoptotic protein(s) is blocked.

PMID:
19115040
[PubMed - indexed for MEDLINE]
PMCID:
PMC2754848
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk